CRN Disputes FDA’s Interpretation Of Labeling Requirements In AER Law
This article was originally published in The Tan Sheet
Executive Summary
The Council for Responsible Nutrition takes issue with FDA's suggested labeling requirements likely to be included in an industry guidance on the adverse reporting law for monograph OTCs and dietary supplements